TITLE

Effect of Beta-blockade and ACE Inhibition on B-type Natriuretic Peptides in Stable Patients with Systolic Heart Failure

AUTHOR(S)
Jens Rosenberg; Finn Gustafsson; Willem Remme; Günter Riegger; Per Hildebrandt
PUB. DATE
August 2008
SOURCE
Cardiovascular Drugs & Therapy;Aug2008, Vol. 22 Issue 4, p305
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract Introduction  The long-term effect of beta-blockade on the plasma levels of natriuretic peptides BNP and its N-terminal counterpart, NT-proBNP, as risk markers in heart failure (HF) is obscure. Methods  Stable systolic HF patients from the CARMEN study were divided in groups matching their randomised treatment allocation: Carvedilol, enalapril or carvedilol究ꕪ髢. Changes in BNP and NT-proBNP from baseline to 6 months maintenance visit were evaluated in each treatment arm. Furthermore, the prognostic value of BNP and NT-proBNP during monotherapy with carvedilol was assessed with univariate Cox proportional hazards models using a combined endpoint of all cause mortality and cardiovascular hospitalisation. Results  NT-proBNP and BNP were significantly reduced after six months treatment with enalapril (NT-proBNP 1,303 to 857 pg/ml (P P = 0.003), BNP 117 to 93 pg/ml (P = 0.01)). In contrast, no change was observed in the carvedilol group (NT-proBNP 907 to 1,082 pg/ml (P = 0.06), BNP 114 to 130 pg/ml (P = 0.15). The prognostic value of NT-proBNP and BNP was maintained in the carvedilol group (NT-proBNP HR 1.018 95% CI (1.005–1.032), BNP 1.171 (1.088–1.260)). Conclusion  Treatment of HF patients with carvedilol alone does not reduce levels of natriuretic peptides, but treatment with enalapril does. Both BNP and NT-proBNP predict death and hospitalisation in HF patients treated with carvedilol for six months. The clinical implication of our results is that NT-proBNP and BNP can be used as risk markers of death and cardiovascular hospitalisations in systolic HF patients receiving carvedilol without ACE inhibition.
ACCESSION #
33328048

 

Related Articles

  • Study of beta blocker in post-MI bracydardia or heart block.  // Cardiovascular Devices & Drugs;Mar2008, Vol. 14 Issue 3, p24 

    The article reports on the plan of Feinberg School of Medicine at Northwestern University in Evanston, Illinois to conduct a study that will investigate whether a pacemaker-enabled administration of beta-blockers in patients with post-myocardial infarction bradycardia or heart block will also...

  • Beta-blockers in heart failure. Newson, Louise // GP: General Practitioner;2/2/2007, p45 

    The article focuses on the use of beta-blockers in heart failure (HF). The author thinks that HF is a common but poorly managed condition. In the Cardiac Insufficiency Bisoprolol Trial II, the Carvedilol Prospective Randomised Cumulative Survival Study (COPERNICUS) and the Metoprolol Randomised...

  • Guidelines updated for use of perioperative β-blockade.  // PharmacoEconomics & Outcomes News;12/12/2009, Issue 593, p3 

    The article reports on the changes made to the guidelines for the clinical application of perioperative Î’-blockade. The guidelines, which was developed by the American College of Cardiology Foundation/American Heart Association (ACCF/AHA), was updated to depict the developments in the use of...

  • Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study. Maison, Patrick; Cunin, Patrick; Hemery, François; Fric, Florence; Elie, Nicole; Del'Volgo, Aldo; Dubois-Randé, Jean; Hittinger, Luc; Macquin-Mavier, Isabelle // European Journal of Clinical Pharmacology;Jul2005, Vol. 61 Issue 5/6, p445 

    Objectives: Trials in chronic heart failure (CHF) include few patients older than 75 years, who represent a large proportion of CHF patients. We evaluated the influence of age on CHF-medication use and of CHF medications on hospitalisation in patients older than 75 years. Methods: Included in...

  • MISSION! accomplished in acute MI care.  // PharmacoEconomics & Outcomes News;1/27/2007, Issue 520, p8 

    The article discusses research being done on the MISSION! protocol for patients with acute myocardial infarction. It references a study by S. S. Liem et al published in the January 2007 issue of "American Heart Journal." According to researchers from The Netherlands, many MISSION! patients were...

  • Two beneficial heart medicines are still underprescribed.  // Geriatrics;Feb97, Vol. 52 Issue 2, p66 

    Reports that beta blockers and angiotensin converting enzyme (ACE) inhibitors, two classes of cardiovascular medications, are still being underused in treatment of heart disease despite repeated reports of their efficacy. Significance of beta blockers in reducing mortality rates; Reasons for...

  • Most needy miss out on Î’-blockers.  // Pulse;10/4/2004, Vol. 64 Issue 39, p7 

    Reports that patients who would benefit most from beta blockers are least often receiving them in Great Britain. Conditions prevented by beta blockers.

  • Hypertension: Which drugs to choose for patients with cardiovascular disease. Wexler, Randy; Feldman, David // Journal of Family Practice;Apr2006, Vol. 55 Issue 4, p291 

    The article presents recommendations for treating patients with cardiovascular diseases such as heart failure, coronary artery disease and stroke. Hypertension is linked to heart failure cases, heart attacks and first-time strokes. A study was conducted that aims to identify a drug that will...

  • Incident acute coronary syndromes in chronic dialysis patients in the United States[sup 1]. Trespalacios, Fernando C.; Taylor, Allen J.; Agodoa, Lawrence Y.; Abbott, Kevin C. // Kidney International;Nov2002, Vol. 62 Issue 5, p1799 

    Background. Patients on dialysis have a disproportionately high rate of cardiovascular disease (CVD). However, the incidence and risk factors for incident acute coronary syndromes (ACS) have not been previously assessed in dialysis patients. Methods. We analyzed the United States Renal Data...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics